查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012906

血液採集市場：全球市場按產品類型、技術、應用和最終用戶分類的預測 - 2026-2032 年

Blood Collection Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年血液採集市場價值135.9億美元，預計2026年將成長至143.2億美元，複合年成長率為7.15%，到2032年將達到220.5億美元。

主要市場統計數據
基準年 2025 135.9億美元
預計年份：2026年 143.2億美元
預測年份 2032 220.5億美元
複合年成長率 (%) 7.15%

這本權威的入門書籍著重介紹醫療環境中的安全性、操作效率和臨床效用，並在當前醫療實踐的背景下說明了現代採血方法。

血液採樣是臨床診斷、治療方案製定和生物醫學研究的基礎，其方法也在不斷發展，因為安全性、效率和數據完整性變得至關重要。現代實務力求在傳統血液採樣技術與設備設計、安全工程和封閉式系統技術創新之間取得平衡，所有這些創新都旨在最大限度地減少檢測前變異性，同時保護患者和醫護人員的安全。本書整理了臨床醫生、檢查室管理人員和供應鏈專業人員在日常工作中面臨的實際操作問題，涵蓋了從檢體完整性到庫存管理和設備相容性等諸多方面。

策略性地整合關鍵變革，這些變革正在重塑血液採集，其驅動力是技術進步、監管壓力和營運預期。

在技​​術成熟、監管完善以及對安全性和患者體驗日益重視的推動下，血液採集領域正經歷著一場變革。隨著檢查室和醫院努力減少分析前誤差並保護工作人員免受感染，自動化和封閉式系統解決方案已從小眾選擇發展成為主流。同時，材料創新、安全針頭設計以及整合式真空採血管系統的改進，正逐步提升血液處理和運輸效率，從而簡化工作流程並減少血液採集過程中的併發症。

對近期美國關稅措施如何影響整個血液採集供應鏈的採購方式、供應商策略和業務永續營運計畫進行全面分析。

美國近期實施的關稅措施正對全球血液採集設備和耗材供應鏈產生連鎖反應，影響籌資策略、供應商關係和採購計畫。依賴跨境製造和零件採購的供應商正面臨重新評估其製造地地點和成本分配的壓力。為此，一些供應商正在探索在地採購、雙重採購策略以及合約保障措施，以確保在維持獲利能力和臨床客戶服務水準的同時，保障業務的連續性。

基於細分市場的詳細分析，將產品類型、技術選擇、最終用戶概況和應用優先順序連結起來，以明確採購和臨床影響。

了解市場需要具備細分觀點，從而明確不同的產品系列、技術、終端用戶環境和應用如何形成獨特的需求特徵和採購優先順序。產品類型的區分至關重要，因為配件、採血針、注​​射器和針頭以及真空管路系統各自具有獨特的臨床和物流特性。在注射器和針頭領域，針頭和注射器之間，甚至安全針頭和標準針頭之間的權衡，都會影響安全規程和訓練需求。同時，玻璃和塑膠真空管路在檢體穩定性和運輸方面也存在不同的考量。封閉式系統和開放式系統之間的技術差異決定了機構所需的自動化程度、污染控制水平以及與下游分析儀器的整合程度，而這種選擇通常直接反映了檢查室的處理能力和人員配置模式。

詳細的區域分析揭示了全球主要地區醫療保健基礎設施和法規環境的差異如何影響血液製品的引進和分銷。

區域趨勢顯著影響血液採集產品的引進模式、監管方式和物流，導致美洲、歐洲、中東和非洲以及亞太地區採取不同的策略。在美洲，一體化醫療網路和集中式檢查室鏈推動了對支援高通量工作流程和標準化安全措施的解決方案的需求，而監管重點則放在醫療設備標籤和上市後監測上。放眼東方，歐洲、中東和非洲地區的管理體制和基礎設施成熟度呈現出多元化的特點，這既為大都會圈的先進系統提供了機遇，也為供應鏈複雜、資源受限地區的實用且經濟高效的方案提供了可能。

全面概述競爭策略，揭示產品創新、檢驗和服務模式如何決定血液採集市場的領導地位和差異化優勢。

血液採集領域的競爭動態主要圍繞著產品差異化、安全性、生產規模和端到端服務能力。成熟的醫療設備製造商憑藉檢驗的安全設計、涵蓋從針頭到真空系統的豐富產品系列以及可靠的供應鏈，在競爭中佔據優勢。而專注於特定領域的企業則致力於新型材料、一次性創新或符合人體工學的設計，以縮短操作時間並提高使用者依從性。組件專家與系統整合商之間的合作正逐漸成為一種有效的策略，既能分散研發風險，又能加快改進型解決方案的上市速度。

為旨在增強韌性、加快採用更安全技術以及使採購與臨床優先事項保持一致的領導者提供一系列實用建議。

行業領導者應採取一系列協調一致的行動，以增強韌性，加速採用更安全的技術，並使採購與不斷變化的臨床優先事項保持一致。首先，各機構應優先與那些提供透明的零件採購和彈性生產方案，並能快速應對貿易政策和物流中斷的供應商建立合作關係。其次，將封閉式系統技術和安全設計的設備整合到標準化流程中，可以減少操作差異並降低手術風險。領導者必須平衡有針對性的培訓計畫和實際部署，以確保現場具備相應的能力。

本說明了用於產生關於血液採樣可靠見解的透明調查方法，描述了主要和次要調查過程、檢驗程序和分析框架。

本研究途徑結合了一手和二手資料研究，並採用嚴格的檢驗程序，以深入了解血液採集的實踐、技術和商業性趨勢。一手資料研究包括對臨床負責人、檢查室經理、採購專員和供應商代表進行結構化訪談，以了解實際操作情況、產品偏好以及對近期政策變化的反應。二手資料研究則包括對監管指南、標準文件、技術規範和同行評審文獻的全面審查，以支持基於既有證據的研究結果，並對一手資料訪談中提出的觀點進行嚴格檢驗。

將安全、供應鏈、細分和區域挑戰整合起來，得出簡潔的結論，並將其作為相關人員。

這項結論整合了本報告的核心主題：以安全為中心的創新、供應鏈的適應性、與細分市場相契合的產品策略以及針對特定區域的商業性策略。這些主題共同構成了一個生態系統，在這個系統中，臨床品質、營運穩健性和法規遵從性相互交融，共同決定著企業的長期成功。採用整合解決方案（結合檢驗的設備設計、一致的培訓計劃和多元化的採購管道）的機構，將更有能力最大限度地降低風險，並支持高品質的診斷結果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 血液採集市場：依產品類型分類

  • 配件
  • 《採血針》
  • 注射器/針頭
    • 針
      • 安全針
      • 標準針頭
    • 注射器
  • 真空管系統
    • 玻璃真空管
    • 塑膠真空管

第9章 血液採集市場：依技術分類

  • 封閉式系統
  • 開放系統

第10章 血液採集市場：依應用領域分類

  • 血庫
  • 臨床診斷
  • 研究

第11章 血液採集市場：依最終用戶分類

  • 門診部
  • 診斷檢查室
  • 居家照護
  • 醫院
  • 研究機構

第12章 血液採集市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 血液採集市場：依血型分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 血液採集市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國血液採集市場

第16章：中國採血市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • CSL Limited
  • Danaher Corporation
  • Fresenius Kabi AG
  • Greiner Bio-One International GmbH
  • Grifols, SA
  • Haemonetics Corporation
  • ICU Medical, Inc.
  • Kabe Labortechnik GmbH
  • Maco Pharma International GmbH
  • Medline Industries, Inc.
  • Nipro Corporation
  • QIAGEN NV
  • Sarstedt AG & Co. KG
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-437D459580D9

The Blood Collection Market was valued at USD 13.59 billion in 2025 and is projected to grow to USD 14.32 billion in 2026, with a CAGR of 7.15%, reaching USD 22.05 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 13.59 billion
Estimated Year [2026] USD 14.32 billion
Forecast Year [2032] USD 22.05 billion
CAGR (%) 7.15%

An authoritative introduction that contextualizes contemporary blood collection practices by highlighting safety, operational efficiency, and clinical utility across care settings

Blood collection underpins clinical diagnostics, therapeutic decision-making, and biomedical research, and it continues to evolve as safety, efficiency, and data integrity gain prominence. Modern practice now balances traditional phlebotomy techniques with innovations in device design, safety engineering, and closed-system technologies that collectively aim to minimize pre-analytical variability while protecting patients and healthcare workers. This introduction frames the operational realities that clinicians, laboratory managers, and supply chain professionals confront daily, from specimen integrity concerns to the practicalities of inventory management and device compatibility.

Across healthcare settings, stakeholders prioritize protocols that reduce contamination risk, improve workflow throughput, and enable reliable downstream testing. Consequently, manufacturers and procurement teams must align around interoperable systems, training regimens, and clear quality metrics to ensure consistent outcomes. By situating blood collection within this broader clinical and research ecosystem, the introduction sets expectations for how the subsequent sections address technological inflection points, regulatory pressures, procurement shifts, and practical recommendations that drive safer, more efficient specimen collection.

A strategic synthesis of the major transformative shifts reshaping blood collection driven by technology advances, regulatory pressures, and operational expectations

The blood collection landscape is undergoing transformative shifts driven by technological maturation, regulatory refinement, and a heightened focus on safety and patient experience. Automation and closed-system solutions have progressed from niche options to mainstream considerations as laboratories and hospitals seek to reduce pre-analytical errors and protect staff from exposure. At the same time, innovations in materials, safety needle design, and integrated vacuum tube systems have enabled incremental improvements in handling and transportation, resulting in smoother workflows and fewer sampling complications.

Regulatory frameworks have intensified scrutiny on device labeling, adverse event reporting, and safety-engineered products, prompting manufacturers to accelerate validation efforts and enhance supply chain transparency. Concurrently, end users are demanding devices that simplify training and reduce time-to-competency for frontline staff. These converging trends are reshaping procurement evaluation criteria and encouraging broader adoption of standardized protocols. As a result, organizations that proactively adapt to these shifts by aligning procurement, clinical training, and supplier partnerships will be better positioned to realize efficiency gains and sustain compliance in a more exacting environment.

An integrated analysis of how recent United States tariff interventions have influenced procurement approaches, supplier strategies, and continuity planning across blood collection supply chains

Recent tariff measures originating from the United States have ripple effects across the global supply chain for blood collection devices and consumables, influencing sourcing strategies, vendor relationships, and procurement planning. Suppliers that rely on cross-border manufacturing and component sourcing face pressure to reassess manufacturing footprints and cost allocations. In response, some vendors have explored local sourcing, dual-sourcing strategies, and contractual protections to maintain continuity while protecting margins and preserving service levels for clinical customers.

For healthcare providers and laboratory networks, these trade policy shifts have prompted closer collaboration with suppliers to mitigate disruption risk. Procurement teams are increasingly evaluating total landed cost rather than unit price alone, integrating considerations such as lead time variability, customs processing, and inventory carrying costs into purchasing decisions. Moreover, the uncertainty introduced by tariff dynamics has accelerated conversations about supplier diversification, onshoring of critical components, and strategic stockpiling where feasible. Taken together, these adjustments underscore the importance of agile sourcing models and transparent supplier communication to sustain uninterrupted access to essential blood collection products.

A deep segmentation-driven narrative connecting product types, technology choices, end-user profiles, and application priorities to clarify procurement and clinical implications

Understanding the market requires a segmentation-aware perspective that clarifies how different product families, technologies, end-user environments, and applications create distinct demand profiles and procurement priorities. Product type distinctions matter because Accessories, Lancets, Syringes & Needles, and Vacuum Tube Systems each present unique clinical and logistical attributes; within syringes and needles the trade-offs between needles and syringes, and further between safety needles and standard needles, influence both safety protocols and training needs, while glass and plastic vacuum tubes present different considerations for sample stability and transport. Technology segmentation between closed systems and open systems defines the degree of automation, contamination control, and integration with downstream analyzers that organizations require, and this choice often maps directly to laboratory throughput and staffing models.

End-user segmentation across ambulatory care centers, diagnostic laboratories, home care settings, hospitals, and research institutes drives procurement behavior because each environment imposes different constraints on device robustness, ease of use, and disposability. Application-driven distinctions-blood banking, clinical diagnostics, and research-further refine requirements for traceability, sample volume, and storage conditions. Consequently, product design, training programs, and distribution models must align with these layered segmentation realities. By synthesizing product, technology, end-user, and application perspectives, stakeholders can better tailor offering portfolios, clinical protocols, and supply chain configurations to meet nuanced operational needs and deliver consistent specimen quality across contexts.

A nuanced regional analysis revealing how differing healthcare infrastructures and regulatory environments across major global regions shape adoption and logistics for blood collection

Regional dynamics profoundly shape adoption patterns, regulatory approaches, and logistics for blood collection products, leading to differentiated strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, integrated health networks and centralized laboratory chains drive demand for solutions that support high-throughput workflows and standardized safety practices, while regulatory oversight emphasizes device labeling and post-market surveillance. Transitioning eastward, Europe Middle East & Africa presents a mosaic of regulatory regimes and infrastructure maturity levels, creating opportunities for both advanced systems in metropolitan centers and pragmatic, cost-effective options in areas where supply chain complexity or resource constraints persist.

In Asia-Pacific, diverse healthcare investment cycles coexist with rapidly expanding diagnostic networks and growing emphasis on point-of-care capabilities, resulting in a bifurcated market that values both innovation and scalable manufacturing. Logistic considerations, such as cold chain capacity, transportation reliability, and customs efficiency, vary substantially across regions and directly affect the viability of certain product formats and vendor models. As a result, manufacturers and distributors must adapt commercial strategies to these regional nuances by offering tiered portfolios, localized service models, and regulatory support that reflect distinct regional priorities and operational realities.

An insightful overview of competitive strategies demonstrating how product innovation, validation, and service models determine leadership and differentiation in blood collection markets

Competitive dynamics in the blood collection space center on product differentiation, safety credentials, manufacturing scale, and end-to-end service capabilities. Established device manufacturers compete on the basis of validated safety-engineered designs, broad product portfolios that span needles to vacuum systems, and demonstrated supply chain reliability. Meanwhile, niche players specialize in novel materials, single-use innovations, or ergonomic designs that reduce procedure time and improve user compliance. Partnerships between component specialists and full-system integrators have emerged as a potent strategy to accelerate time-to-market for improved solutions while spreading development risk.

Investment in clinical validation, regulatory dossiers, and post-market surveillance supports commercial credibility and buyer confidence. Concurrently, companies pursuing global expansion prioritize localized manufacturing, distribution partnerships, and stronger after-sales training programs to differentiate on service rather than price alone. Strategic moves also include platform standardization to reduce compatibility friction for laboratories and bundled offerings that align devices with consumables and training. These competitive behaviors indicate that success will favor organizations combining product rigor with operational responsiveness and a clear narrative on safety and reliability.

A pragmatic set of actionable recommendations for leaders aiming to strengthen resilience, accelerate safer technology adoption, and align procurement with clinical priorities

Industry leaders should pursue a coordinated set of actions that reinforce resilience, accelerate adoption of safer technologies, and align procurement with evolving clinical priorities. First, organizations ought to prioritize supplier relationships that offer transparent component sourcing and flexible production options, enabling rapid response to trade policy or logistical disruptions. Second, integrating closed-system technologies and safety-engineered devices into standardized protocols will reduce variability and lower procedural risk; leaders must balance implementation with targeted training programs that ensure frontline competency.

Third, companies should invest in clinical validation studies that demonstrate operational benefits such as reduced pre-analytical error and improved staff safety, thereby strengthening the case for capital allocation. Fourth, aligning portfolio strategies to regional infrastructure and regulatory nuances will improve market fit and reduce time-to-adoption. Finally, leaders should cultivate cross-functional governance that links procurement, clinical leadership, and supply chain teams, enabling faster decision-making and coordinated contingency planning. Taken together, these actions will help organizations realize improved clinical outcomes while maintaining operational agility in a dynamic environment.

A transparent methodology exposition describing primary and secondary research processes, validation steps, and analytical frameworks used to produce credible blood collection insights

The research approach blends primary and secondary inquiry with rigorous validation steps to generate reliable insights about blood collection practices, technologies, and commercial dynamics. Primary research included structured interviews with clinical leaders, laboratory managers, procurement specialists, and supplier representatives to capture operational realities, product preferences, and responses to recent policy changes. Secondary research comprised an exhaustive review of regulatory guidance, standards documentation, technical specifications, and peer-reviewed literature to ground findings in established evidence and to triangulate claims made during primary interviews.

Analytical frameworks included segmentation overlays, scenario testing for supply chain disruptions, and qualitative assessments of competitive positioning. Quality controls involved cross-validation of interview claims against documentary evidence, peer review of analytical assumptions, and consistency checks across regional profiles. This layered methodology ensures that conclusions reflect both lived operational experience and corroborated technical detail, providing stakeholders with an actionable synthesis that supports strategic and tactical decision-making.

A concise conclusion that synthesizes safety, supply chain, segmentation, and regional imperatives into a coherent strategic framework for stakeholders

The conclusion synthesizes the report's core themes: safety-centric innovation, supply chain adaptability, segmentation-aligned product strategies, and region-specific commercial approaches. Collectively, these themes denote an ecosystem in which clinical quality, operational robustness, and regulatory diligence converge to determine long-term success. Organizations that embrace integrated solutions-blending validated device design, coherent training programs, and diversified sourcing-will be better positioned to minimize risk and support high-quality diagnostic outcomes.

Looking ahead, continuous monitoring of technological advances and policy developments will remain essential. Stakeholders should treat the conclusion as a strategic waypoint: it summarizes current imperatives and provides a landing point from which to plan investments, partnerships, and capability development. Ultimately, the evolving landscape rewards proactive, well-coordinated responses that translate research insights into measurable operational improvements and enhanced patient safety.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Collection Market, by Product Type

  • 8.1. Accessories
  • 8.2. Lancets
  • 8.3. Syringes & Needles
    • 8.3.1. Needles
      • 8.3.1.1. Safety Needles
      • 8.3.1.2. Standard Needles
    • 8.3.2. Syringes
  • 8.4. Vacuum Tube Systems
    • 8.4.1. Glass Vacuum Tubes
    • 8.4.2. Plastic Vacuum Tubes

9. Blood Collection Market, by Technology

  • 9.1. Closed Systems
  • 9.2. Open Systems

10. Blood Collection Market, by Application

  • 10.1. Blood Banking
  • 10.2. Clinical Diagnostics
  • 10.3. Research

11. Blood Collection Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Diagnostic Laboratories
  • 11.3. Home Care
  • 11.4. Hospitals
  • 11.5. Research Institutes

12. Blood Collection Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Blood Collection Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Blood Collection Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Blood Collection Market

16. China Blood Collection Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. B. Braun Melsungen AG
  • 17.7. Becton, Dickinson and Company
  • 17.8. Cardinal Health, Inc.
  • 17.9. CSL Limited
  • 17.10. Danaher Corporation
  • 17.11. Fresenius Kabi AG
  • 17.12. Greiner Bio-One International GmbH
  • 17.13. Grifols, S.A.
  • 17.14. Haemonetics Corporation
  • 17.15. ICU Medical, Inc.
  • 17.16. Kabe Labortechnik GmbH
  • 17.17. Maco Pharma International GmbH
  • 17.18. Medline Industries, Inc.
  • 17.19. Nipro Corporation
  • 17.20. QIAGEN N.V.
  • 17.21. Sarstedt AG & Co. KG
  • 17.22. Terumo Corporation
  • 17.23. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD COLLECTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD COLLECTION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD COLLECTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD COLLECTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD COLLECTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BLOOD COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BLOOD COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD COLLECTION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD COLLECTION MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD COLLECTION MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD COLLECTION MARKET SIZE, BY LANCETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD COLLECTION MARKET SIZE, BY LANCETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD COLLECTION MARKET SIZE, BY LANCETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD COLLECTION MARKET SIZE, BY NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD COLLECTION MARKET SIZE, BY NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD COLLECTION MARKET SIZE, BY NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD COLLECTION MARKET SIZE, BY SAFETY NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD COLLECTION MARKET SIZE, BY SAFETY NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD COLLECTION MARKET SIZE, BY SAFETY NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD COLLECTION MARKET SIZE, BY STANDARD NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD COLLECTION MARKET SIZE, BY STANDARD NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD COLLECTION MARKET SIZE, BY STANDARD NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD COLLECTION MARKET SIZE, BY SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD COLLECTION MARKET SIZE, BY SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD COLLECTION MARKET SIZE, BY SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD COLLECTION MARKET SIZE, BY GLASS VACUUM TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD COLLECTION MARKET SIZE, BY GLASS VACUUM TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD COLLECTION MARKET SIZE, BY GLASS VACUUM TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD COLLECTION MARKET SIZE, BY PLASTIC VACUUM TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD COLLECTION MARKET SIZE, BY PLASTIC VACUUM TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD COLLECTION MARKET SIZE, BY PLASTIC VACUUM TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD COLLECTION MARKET SIZE, BY CLOSED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD COLLECTION MARKET SIZE, BY CLOSED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD COLLECTION MARKET SIZE, BY CLOSED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD COLLECTION MARKET SIZE, BY OPEN SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD COLLECTION MARKET SIZE, BY OPEN SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD COLLECTION MARKET SIZE, BY OPEN SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD COLLECTION MARKET SIZE, BY BLOOD BANKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD COLLECTION MARKET SIZE, BY BLOOD BANKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD COLLECTION MARKET SIZE, BY BLOOD BANKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD COLLECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD COLLECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD COLLECTION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD COLLECTION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD COLLECTION MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD COLLECTION MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD COLLECTION MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD COLLECTION MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD COLLECTION MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD COLLECTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD COLLECTION MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD COLLECTION MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD COLLECTION MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD COLLECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD COLLECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD COLLECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD COLLECTION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD COLLECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS BLOOD COLLECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD COLLECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GCC BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GCC BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. GCC BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 146. GCC BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 147. GCC BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 148. GCC BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. GCC BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. GCC BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. G7 BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. G7 BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. G7 BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 170. G7 BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 171. G7 BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 172. G7 BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. G7 BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. G7 BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. NATO BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. NATO BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NATO BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 178. NATO BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 179. NATO BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 180. NATO BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. NATO BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. NATO BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL BLOOD COLLECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES BLOOD COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA BLOOD COLLECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA BLOOD COLLECTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA BLOOD COLLECTION MARKET SIZE, BY SYRINGES & NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA BLOOD COLLECTION MARKET SIZE, BY NEEDLES, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA BLOOD COLLECTION MARKET SIZE, BY VACUUM TUBE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA BLOOD COLLECTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA BLOOD COLLECTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA BLOOD COLLECTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)